[A review of clinical tumor immunology. An approach to immunochemotherapy].
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D001500:BCG Vaccine; D003561:Cytarabine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005472:Fluorouracil / Q000627:therapeutic use; D005620:Freund's Adjuvant / Q000627:therapeutic use; D006801:Humans; D006968:Hypersensitivity, Delayed; D007109:Immunity; D007111:Immunity, Cellular; D007136:Immunoglobulins / Q000627:therapeutic use; D007167:Immunotherapy; D007962:Leukocytes; D008214:Lymphocytes / Q000276:immunology; D051379:Mice; D009365:Neoplasm Regression, Spontaneous; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D010190:Pancreatic Neoplasms / Q000276:immunology; D013274:Stomach Neoplasms / Q000276:immunology; D013291:Streptococcus; D014118:Toxins, Biological / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D001500:BCG Vaccine; D007136:Immunoglobulins; D014118:Toxins, Biological; D003561:Cytarabine; D005620:Freund's Adjuvant; D005472:Fluorouracil